# Beigene (Suzhou) Co., Ltd. – FDA Inspection, Jun 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/beigene-suzhou-co-ltd/5c7e81b4-6666-4251-a25b-f579017fe7a5
Source feed: FDA_Inspections

> FDA inspection 1217639 of Beigene (Suzhou) Co., Ltd., June 16, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217639
- Company Name: Beigene (Suzhou) Co., Ltd.
- Inspection Date: 2023-06-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1103267 - 2019-08-28

## Related Officers

- [Tonia F. Bernard](https://www.keypedia.com/people/tonia-f-bernard/607c8dae-63cb-491a-8d7d-ddfa0ee1b67d)
- [Yiwei Li](https://www.keypedia.com/people/yiwei-li/e5ea2c24-8e1e-43be-be23-e276b8848cff)
- [Zhong Li](https://www.keypedia.com/people/zhong-li/18545b20-7fa5-4850-9dd4-cffb40c41f8d)

Company: https://www.keypedia.com/companies/beigene-suzhou-co-ltd/10b8c1b1-d4b8-4272-a5bd-d1615d0df568

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c